Consortium on Beta cell Death and Survival (CBDS) HIRN (UC4) | Apply Online

Opportunity Summary:

The Consortium on Beta cell Death and Survival (CBDS) HIRN (UC4) grant opportunity (Funding Opportunity Number RFA-DK-13-018) was a National Institutes of Health (NIH) cooperative agreement intended to launch a coordinated research consortium focused on one central problem in type 1 diabetes (T1D): how and why human pancreatic beta cells become stressed, damaged, and ultimately destroyed. The program sits within the larger Human Islet Research Network (HIRN) framework, meaning funded groups were expected to operate as part of a broader NIH-organized, multi-team network rather than as isolated single-lab projects. The core mission of CBDS was to better define the mechanisms driving beta cell stress and death in humans and to improve the ability to detect these processes, with the long-term clinical goal of protecting the remaining (residual) beta cell mass in people with T1D as early in the disease course as possible. In practical terms, the FOA emphasized understanding disease-relevant pathways and developing approaches that could help identify beta cell injury earlier and guide strategies to preserve function.

This FOA used the UC4 cooperative agreement mechanism, which typically signals substantial NIH programmatic involvement and an expectation of active collaboration, shared milestones, and coordinated governance across awardees. The activity area was listed under Food and Nutrition/Health, with the CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research), indicating administration through NIH institutes focused on diabetes and related conditions. The opportunity did not require cost sharing or matching, so applicants were not expected to provide a formal financial match to receive support.

Funding levels were sized for a consortium rather than a single small project. The estimated total funding amount was about $9,000,000, and the award ceiling was $600,000, indicating an upper limit on how much could be requested per award (typically per year, depending on the FOA structure). The announcement was posted on September 26, 2013, and it originally closed on February 27, 2014, with the archive date listed as March 30, 2014, meaning it is no longer an active competition but remains available for reference.

Eligibility was broad and included many types of domestic organizations such as public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status), state and local governments, tribal governments and tribal organizations, special district governments, public housing/Indian housing authorities, and for-profit organizations other than small businesses, along with small businesses as well. The eligibility language also explicitly included a range of mission-focused and community-serving institution types (for example, HBCUs, Hispanic-serving institutions, AANAPISIs, TCCUs, Alaska Native and Native Hawaiian-serving institutions, and faith-based or community-based organizations). Importantly, foreign organizations and foreign institutions were eligible to apply, foreign components were allowed under NIH policy, and non-U.S. components of U.S. organizations could participate, which is notable for a consortium designed to tackle human biology questions that can benefit from international cohorts, specialized expertise, or unique sample resources.

Operationally, applicants were directed to the full FOA text hosted on the NIH grants website (link provided in the source data), and the announcement included standard NIH contact guidance for technical difficulties accessing or linking to the funding notice through the NIH Office of Extramural Research (OER) webmaster. Overall, the CBDS HIRN (UC4) opportunity was designed to bring multiple investigators and institutions into a tightly coordinated effort to map and measure beta cell stress and death mechanisms in humans, aiming to translate that knowledge into earlier detection and ultimately better strategies to preserve beta cell mass in T1D.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition Health

Next opportunity: JFSP New Science Initiative Social Science Announcement (1 Task Statement)

Previous opportunity: Consortium on Modeling Autoimmune Interactions (CMAI) HIRN (UC4)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DK 13 018

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DK 13 018) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 13 018", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.